Pharmaceutical & Food
Chinese Sinopharm vaccine 84 pct efficacy against COVID-19 mortality -- Argentine health ministry2021-07-12
The COVID-19 vaccine developed by Chinese pharmaceutical company Sinopharm is 84 percent effective in preventing death from the disease, showed a report by the Argentine Ministry of Health.
60e25ca8a310efa1e3ac4f1d.png TCM spreads its wings across the globe2021-07-05
The popularity of TCM can be traced back more than 40 years, when China launched reform and opening-up. It was also when Harish Chandra Shah, the first TCM practitioner in Nepal, visited Beijing to study Chinese medicine.
Chinese vaccines effective against COVID-19 Delta variant: top epidemiologist2021-06-26
China's top epidemiologist Zhong Nanshan said on Friday that Chinese vaccines are effective against the COVID-19 Delta variant, and he urged more people to be vaccinated.
Chinese vaccine maker aims to increase global markets2021-06-22
China National Biotech Group, a subsidiary of pharmaceutical giant Sinopharm, has made unprecedented forays into the global vaccine market amid the COVID-19 pandemic, said Zhang Yuntao, vice-president of the company.
Nation pushes overseas vaccine production2021-06-08
China is encouraging the production of more of its vaccines in overseas countries, especially developing ones, to help ensure supplies and speed the global economic recovery, according to officials and analysts.
Efficacy of Sinopharm vaccines tops 70%, study finds2021-05-28
Domestic drugmaker Sinopharm's two vaccines are both more than 70 percent effective against symptomatic cases of COVID-19, according to a study published on Wednesday on the world's first third-stage clinical trial of inactivated vaccines.
China's Sinovac vaccine stands out in protecting health workers in Indonesia: health ministry2021-05-13
China's Sinovac vaccine against COVID-19 has appeared to be highly efficacious, as an overwhelming majority of vaccinated health workers were found protected from death and hospitalization, according to a Bloomberg report on Wednesday.
Firms go all out to meet global vaccine demand2021-05-13
Chinese vaccine makers have been stepping up efforts to improve the manufacturing and equitable use of COVID-19 vaccines around the world by offering expertise, technical assistance and production licensing to countries that hope to have access to high-quality and affordable vaccines.
China's new recombinant COVID-19 vaccine starts human tests2021-04-25
Sinopharm, the Chinese pharmaceutical giant, has commenced phase-1 and phase-2 clinical trials for its new recombinant vaccine against COVID-19 in central China's Henan Province since Saturday.
???藉??_????.jpg China to produce more than 3 bln COVID-19 vaccines this year: official2021-04-21
China is expected to produce more than 3 billion COVID-19 vaccine doses this year, an official said Tuesday.
Sinovac vaccine effective: Chilean study2021-04-18
The CoronaVac vaccine developed by Chinese pharmaceutical firm Sinovac is up to 67 percent effective in preventing symptomatic COVID-19, Chile's Ministry of Health said on Friday.
Sinovac vaccine to expand annual production capacity2021-04-03
The third production line of CoronaVac, an inactivated COVID-19 vaccine developed by Sinovac Biotech, was completed and put into production on Thursday. It will likely expand the company's annual production capacity to 2 billion doses.
Industry leaders seek TCM patent protection2021-03-22
Traditional Chinese Medicine practitioners and industry leaders applauded the granting of a patent last year for Qingfei Paidu Soup, an herbal decoction that proved effective in treating COVID-19.
US tariff move helps 99 medical product categories2021-03-12
The United States is extending tariff exclusions on about 99 categories of medical products from China until Sept 30, to support the fight against COVID-19, the US Trade Representative office said on Wednesday.
Most Popular
BACK TO TOP
Edition:
Chinese | BIG5 | Deutsch
Link:    
About CE.cn | About the Economic Daily | Contact us
Copyright 2003-2020 China Economic Net. All right reserved